Feasibility study of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma
Not Applicable
- Conditions
- metastatic lung tumors from adenoid cystic carcinoma
- Registration Number
- JPRN-UMIN000032875
- Lead Sponsor
- Kanto Neurosurgical Hospital
- Brief Summary
The patient underwent SBRT at 60 Gy in 10 sequential fractions for each tumor. The biologically effective dose based on an alpha/beta ratio of 2 Gy was 240 Gy per tumor. The percentage of the total lung volume irradiated with >20 Gy was 4.9%, 3.2%, and 2.6% for each tumor.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
Not provided
Exclusion Criteria
The presence of other primary cancers
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Toxicity
- Secondary Outcome Measures
Name Time Method